Action 688289 SANSURE BIOTECH INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Sansure Biotech Inc.

Actions

688289

CNE1000043J1

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 24/04/2024 		Varia. 5j. Varia. 1 janv.
18,7 CNY +1,08 % Graphique intraday de Sansure Biotech Inc. +2,47 % -4,35 %
29/02 Les bénéfices de Sansure Biotech pour 2023 chutent de 81% et les recettes de 84% MT
28/02 Sansure Biotech Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84%
Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
ASEP Medical Holdings Signs JV Agreement with Chinese Medical Diagnostics Co Sansure Biotech Inc.
Sansure Biotech Secures EU Certification For In Vitro Diagnostic Device
Sansure Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.
Sansure Biotech Inc.'s Equity Buyback announced on October 21, 2022, has closed with 9,865,793 shares, representing 1.7% for CNY 200 million.
Sansure Biotech Gets EU CE certification for 60 products
Certain A Shares of Sansure Biotech Inc. are subject to a Lock-Up Agreement Ending on 28-AUG-2023.
Sansure Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Sansure Biotech's Human Papillomavirus Kit Gets EU Registration Certificate
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.
Sansure Biotech Inc.(SHSE:688289) dropped from Shanghai Stock Exchange Health Care Sector Index
Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.
Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Asep Inc. Lower After Signing JV Term Sheet with Leading Chinese Medical Diagnostic Co. Sansure Biotech Inc.
Sansure Biotech Gets Certification for COVID-19 Kit
ASEP Medical Holdings Inc. Signs Joint Venture Term Sheet with Sansure Biotech Inc. in Preparation for the Commercialization of the Sepset(ER) Sepsis Diagnostic Test in China
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 688289
  4. Actualités Sansure Biotech Inc.
  5. Autres langues